Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Heart pump patients may ditch aspirin safely, new trial hopes

NCT ID NCT07644247

First seen Jun 15, 2026 · Last updated Jun 18, 2026 · Updated 1 time

Summary

This study looks at whether people with a CH-VAD heart pump can safely stop taking aspirin. About 370 participants will either get a placebo or continue aspirin, along with their standard blood thinner. The goal is to see if removing aspirin reduces bleeding problems without raising the risk of dangerous clots or stroke.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STROKE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Conditions

The condition(s) this trial relates to.

advanced heart failure Hemorrhage hemorrhagic disease stroke disorder thrombotic disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.